Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Psychemedics Corporation (PMD : NSDQ)

• Company Description    Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry. Number of Employees: 101

• Price / Volume Information    Yesterday's Closing Price: $ Daily Weekly Monthly 20 Day Moving Average: shares Shares Outstanding: 6.11 (millions) Market Capitalization: $ (millions) Beta: 52 Week High: $3.25 52 Week Low: $1.63 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week % % 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5220 Spring Valley Road - Dallas,TX 75254 USA ph: 800-527-7424 fax: 978-264-9236 None http://www.psychemedics.com

• General Corporate Information    Officers Brian Hullinger - Chief Executive Officer and President Daniella Mehalik - Vice President of Finance and Treasurer Robyn C. Davis - Director Peter H. Kamin - Director Darius G. Nevin - Director Peer Information Psychemedics Corporation (CMTI) Psychemedics Corporation (CMWLQ) Psychemedics Corporation (AHG.) Psychemedics Corporation (ROIX) Psychemedics Corporation (M.DCE) Psychemedics Corporation (DHSM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-OUTP/HM CRE Sector: Medical CUSIP: 744375304 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/24 Next Expected EPS Date: 08/12/25 Share - Related Items Shares Outstanding: 6.11 Most Recent Split Date: 8.00 (0.25:1) Beta: Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: % Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 118.75% vs. Previous Quarter: 133.33% Sales Growth vs. Year Ago Period: -11.46% vs. Previous Quarter: -14.90% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - -32.32 ROA 06/30/25 - - 03/31/25 - - 12/31/24 - -18.53 Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.82 Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.82 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -9.26 Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -9.26 Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -9.73 Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - 0.84 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - 0.01 Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - 1.02

Powered by Zacks Investment Research ©